Clinical Trials Browser

Metastatic Castration-resistant Prostate Cancer × darolutamide × Genitourinary × Clear all

NCT07244341 2026-02-04

A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)

Phase 1 Recruiting

Metastatic Castration-resistant Prostate Cancer

NCT06401980 2025-08-14

Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Phase 2 Recruiting

Metastatic Castration-resistant Prostate Cancer

NCT05762536 2024-06-27

DAROTAXEL

Phase 2 Recruiting

Metastatic Castration-resistant Prostate Cancer